Have a feature idea you'd love to see implemented?
Let us know!
SAVA Cassava Sciences Inc
Price (delayed)
$32.18
Market cap
$1.55B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.37
Enterprise value
$1.36B
Cassava Sciences' mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to
Highlights
Cassava Sciences's EPS has soared by 84% YoY and by 8% from the previous quarter
The net income has soared by 81% YoY but it has contracted by 15% from the previous quarter
Cassava Sciences's equity has decreased by 12% from the previous quarter but it has increased by 7% YoY
The quick ratio has dropped by 59% year-on-year and by 13% since the previous quarter
Key stats
What are the main financial stats of SAVA
Market
Valuations
Earnings
Shares outstanding
48.11M
Market cap
$1.55B
Enterprise value
$1.36B
Price to earnings (P/E)
N/A
Price to book (P/B)
9.26
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$17.66M
EBITDA
-$16.44M
Free cash flow
-$78.07M
Per share
Balance sheet
Liquidity
EPS
-$0.37
Free cash flow per share
-$1.63
Book value per share
$3.47
Revenue per share
$0
TBVPS
$4.66
Total assets
$223.75M
Total liabilities
$57.11M
Debt
$0
Equity
$166.64M
Working capital
$145.52M
Debt to equity
0
Current ratio
3.55
Quick ratio
3.31
Net debt/EBITDA
11.5
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-9.1%
Return on equity
-12.4%
Return on invested capital
N/A
Return on capital employed
-10.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SAVA stock price
How has the Cassava Sciences stock price performed over time
Intraday
23.53%
1 week
23.11%
1 month
11.43%
1 year
44.24%
YTD
42.96%
QTD
9.34%
Financial performance
How have Cassava Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$134.75M
Net income
-$17.66M
Gross margin
N/A
Net margin
N/A
The net income has soared by 81% YoY but it has contracted by 15% from the previous quarter
Cassava Sciences's operating income has decreased by 29% YoY and by 2.1% from the previous quarter
Growth
What is Cassava Sciences's growth rate over time
Valuation
What is Cassava Sciences stock price valuation
P/E
N/A
P/B
9.26
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Cassava Sciences's EPS has soared by 84% YoY and by 8% from the previous quarter
SAVA's P/B is 42% above its 5-year quarterly average of 6.5 and 25% above its last 4 quarters average of 7.4
Cassava Sciences's equity has decreased by 12% from the previous quarter but it has increased by 7% YoY
Efficiency
How efficient is Cassava Sciences business performance
Cassava Sciences's ROA has soared by 80% YoY but it has decreased by 7% from the previous quarter
SAVA's return on equity has surged by 75% year-on-year but it is down by 13% since the previous quarter
Dividends
What is SAVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SAVA.
Financial health
How did Cassava Sciences financials performed over time
The quick ratio has dropped by 59% year-on-year and by 13% since the previous quarter
The current ratio has plunged by 59% YoY and by 13% from the previous quarter
Cassava Sciences's debt is 100% less than its equity
Cassava Sciences's equity has decreased by 12% from the previous quarter but it has increased by 7% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.